Authors: BOLAJI II MORTIMER G GRIMES H TALLON DF ODWYER E FOTTRELL PF

Citation: Ii. Bolaji et al., CLINICAL-EVALUATION OF NEAR-CONTINUOUS ORAL MICRONIZED PROGESTERONE THERAPY IN ESTROGENIZED POSTMENOPAUSAL WOMEN, Gynecological endocrinology, 10(1), 1996, pp. 41-47

Authors: WINGFIELD M OHERLIHY C FINN MM TALLON DF FOTTRELL PF

Citation: M. Wingfield et al., FOLLICULAR AND LUTEAL-PHASE SALIVARY PROGESTERONE PROFILES IN WOMEN WITH ENDOMETRIOSIS AND INFERTILITY, Gynecological endocrinology, 8(1), 1994, pp. 21-25

Authors: ORORKE A KANE MM GOSLING JP TALLON DF FOTTRELL PF

Citation: A. Ororke et al., DEVELOPMENT AND VALIDATION OF A MONOCLONAL-ANTIBODY ENZYME-IMMUNOASSAY FOR MEASURING PROGESTERONE IN SALIVA, Clinical chemistry, 40(3), 1994, pp. 454-458

Authors: BOLAJI II TALLON DF ODWYER E FOTTRELL PF

Citation: Ii. Bolaji et al., ASSESSMENT OF BIOAVAILABILITY OF ORAL MICRONIZED PROGESTERONE USING ASALIVARY PROGESTERONE ENZYME-IMMUNOASSAY, Gynecological endocrinology, 7(2), 1993, pp. 101-110